3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
12
Sarcoma
2
Other hematologic neoplasm
1
Lymphoid
1
CNS
1
Conditions
Neuroblastoma
44
Ganglioneuroblastoma
6
Brain Neoplasms
6
Sarcoma
5
Neoplasms
5
Glioma
5
Glioblastoma
5
Central Nervous System Neoplasms
3
Astrocytoma
3
Optic Nerve Glioma
2
Oligodendroglioma
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Bone Neoplasms
2
Wilms Tumor
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Interventions
Filgrastim
9
X-Rays
7
Phantoms, Imaging
7
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Granulocyte Colony-Stimulating Factor
6
Temozolomide
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Cyclophosphamide
5
Busulfan
5
Stem Cell Transplantation
4
Carboplatin
4
Biopsy
4
Topotecan
3
Thiotepa
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Itraconazole
3
Ifosfamide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
sargramostim
2
palbociclib
2
olaparib
2
liposomal amphotericin B
2
larotrectinib
2
ixabepilone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Doxorubicin
×
CNS
×
Clear all
NCT01095926
2013-06-28
Doxo
University Hospital Muenster
Phase 2
Completed
101 enrolled